PUMA, a Potent Killer With or Without P53

Oncogene - United Kingdom
doi 10.1038/onc.2009.45
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

A Potent Tumor-Reactive P53-Specific Single-Chain TCR Without On- Or Off-Target Autoimmunity in Vivo

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2019English

Chek2ing Out the P53 Pathway: Can Puma Lead the Way?

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2011English

Implication of TAp73 in the P53-Independent Pathway of Puma Induction and Puma-Dependent Apoptosis in Primary Cortical Neurons

Journal of Neurochemistry
BiochemistryMolecular NeuroscienceCellular
2010English

A Randomized Controlled Trial on Patients With or Without Adjuvant Autologous Cytokine-Induced Killer Cells After Curative Resection for Hepatocellular Carcinoma

OncoImmunology
OncologyAllergyImmunology
2015English

Farnesyltransferase Inhibitors Are Potent Lung Cancer Chemopreventive Agents in a/J Mice With a Dominant-Negative P53 and/or Heterozygous Deletion of Ink4a/Arf

Oncogene
Cancer ResearchGeneticsMolecular Biology
2003English

Regulation of PUMA-α by P53 in Cisplatin-Induced Renal Cell Apoptosis

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Anesthesia: With or Without Curare?

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2003English

Compiling With Continuations, or Without? Whatever.

Proceedings of the ACM on Programming Languages
2019English

The Sauna: Killer or Healer?

BMJ
1987English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy